148 related articles for article (PubMed ID: 30993311)
1. Dermatomyositis and MIG.
Ragusa F
Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
[TBL] [Abstract][Full Text] [Related]
2. Dermatomyositis and chemokines.
Elia G
Clin Ter; 2015; 166(2):e118-21. PubMed ID: 25945444
[TBL] [Abstract][Full Text] [Related]
3. The MIG Chemokine in Inflammatory Myopathies.
Paparo SR
Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
[TBL] [Abstract][Full Text] [Related]
4. Sarcoidosis and the Th1 chemokine MIG.
Ragusa F
Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
[TBL] [Abstract][Full Text] [Related]
5. MIG in Cutaneous Systemic Lupus Erythematosus.
Ruffilli I
Clin Ter; 2019; 170(1):e71-e76. PubMed ID: 30789201
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis and the Th1 chemokine MIG.
Paparo SR
Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
[TBL] [Abstract][Full Text] [Related]
7. MIG Th1 chemokine in Vitiligo.
Elia G
Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
[TBL] [Abstract][Full Text] [Related]
8. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
[TBL] [Abstract][Full Text] [Related]
9. The Th1 chemokine MIG in Graves' ophthalmopathy.
Gonnella D
Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
[TBL] [Abstract][Full Text] [Related]
10. Type 1 diabetes and MIG.
Gonnella D
Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
[TBL] [Abstract][Full Text] [Related]
11. CXCL9 chemokine in ulcerative colitis.
Elia G; Guglielmi G
Clin Ter; 2018; 169(5):e235-e241. PubMed ID: 30393811
[TBL] [Abstract][Full Text] [Related]
12. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
13. MIG in Crohn's disease.
Caruso C
Clin Ter; 2019; 170(3):e206-e210. PubMed ID: 31173051
[TBL] [Abstract][Full Text] [Related]
14. Mig chemokine in primary biliary cirrhosis.
Mazzi V
Clin Ter; 2019; 170(3):e211-e215. PubMed ID: 31173052
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis and the alpha chemokine MIG.
Giusti C
Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
17. Sjögren syndrome and MIG.
Ruffilli I
Clin Ter; 2019; 170(6):e478-e482. PubMed ID: 31696913
[TBL] [Abstract][Full Text] [Related]
18. Th1 chemokines in ulcerative colitis.
Ragusa F
Clin Ter; 2015; 166(2):e126-31. PubMed ID: 25945446
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity pneumonitis and alpha-chemokines.
Limongi F; Fallahi P
Clin Ter; 2017; 168(2):e140-e145. PubMed ID: 28383627
[TBL] [Abstract][Full Text] [Related]
20. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
